£6m statin trial raises hope drug can be used to treat multiple sclerosis
9 May 2017
Dr Jeremy Chataway (UCL Institute of Neurology)Ìýis leading a phase 3 trial involving more than 1,000 people with multiple sclerosis (MS) to investigate whether simvastatin could become a treatment for the condition. , ,Ìý, , ,